Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Parasites Hosts Dis ; 61(3): 251-262, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37648230

RESUMO

Schistosomiasis causes significant morbidity and mortality worldwide. This study aimed to assess the effect of schistosomula lung antigen preparation (SLAP) and soluble egg antigen (SEA) on a murine schistosomiasis mansoni model. Ninety laboratory-bred male Swiss albino mice were divided into 6 groups. Two doses of the vaccine were given at 2-week intervals. All mice were subcutaneously infected with 80±10 Schistosoma mansoni cercariae 2 weeks after the last vaccination dose. They were sacrificed 7 weeks post-infection. Parasitological and histopathological studies were conducted to assess the effect of inoculated antigens (single or combined). The results showed that the combination of SLAP and SEA (combination group) led to a significant reduction in worm burden (65.56%), and liver and intestine egg count (59% and 60.59%, respectively). The oogram pattern revealed a reduction in immature and mature eggs (15±0.4 and 10±0.8, respectively) and an increased number of dead eggs in the combination group (P<0.001). In terms of histopathological changes, the combination group showed notably small compact fibrocellular egg granuloma and moderate fibrosis in the liver. A high percentage of destroyed ova was observed in the intestine of the combination group. This study demonstrates for the first time the prophylactic effect of combined SLAP and SEA vaccine. The vaccine induced a significant reduction in the parasitological and pathological impacts of schistosomiasis mansoni in hepatic and intestinal tissues, making it a promising vaccine candidate for controlling schistosomiasis.


Assuntos
Esquistossomose mansoni , Vacinas , Masculino , Animais , Camundongos , Esquistossomose mansoni/prevenção & controle , Vacinação , Fígado , Ovos
2.
J Egypt Soc Parasitol ; 32(2): 475-86, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12214925

RESUMO

ELISA IgG, IgM antibodies and PCR for toxoplasmosis were performed on 55 women with complicated gestation and their babies. Besides, ELISA IgG and IgM were applied on 27 uncomplicated gestation (mothers & babies) and 152 randomly selected individuals. Seropositivity to specific IgG antibodies was 36.4%, 59.2% and 57.9% and for IgM was 27.3%, 7.4% and 10.5% in complicated gestation. uncomplicated gestation and random population respectively. PCR was positive in 20%, 50% and 60% of mothers with abortion, premature deliveries and deliveries of babies with congenital anomalies respectively. 55.5% and 40% were found seropositive for IgG from normal full term babies and abnormal babies. 13% of abnormal babies were IgM positive and 46.6% were PCR positive from the same group.


Assuntos
Imunoglobulina G/sangue , Imunoglobulina M/sangue , Toxoplasma/isolamento & purificação , Toxoplasmose/diagnóstico , Animais , Anticorpos Antiprotozoários/sangue , Estudos de Casos e Controles , DNA de Protozoário/sangue , Egito/epidemiologia , Ensaio de Imunoadsorção Enzimática/métodos , Feminino , Sangue Fetal/imunologia , Sangue Fetal/parasitologia , Doenças Fetais/diagnóstico , Doenças Fetais/epidemiologia , Doenças Fetais/parasitologia , Humanos , Recém-Nascido , Masculino , Reação em Cadeia da Polimerase/métodos , Gravidez , Complicações Parasitárias na Gravidez/diagnóstico , Complicações Parasitárias na Gravidez/epidemiologia , Sensibilidade e Especificidade , Estudos Soroepidemiológicos , Toxoplasma/genética , Toxoplasma/imunologia , Toxoplasmose/epidemiologia , Toxoplasmose Congênita
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...